Replimune Group Inc (REPL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 19.77 is considered Undervalued compared with the five-year average of -6.38. The fair price of Replimune Group Inc (REPL) is between 488.15 to 503.40 according to relative valuation method. Compared to the current price of 7.16 USD , Replimune Group Inc By Undervalued By 98.53%.

Relative Value

Fair Zone

488.15-503.40

Current Price：7.16

98.53%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Replimune Group Inc (REPL) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Replimune Group Inc (REPL) has a current Price-to-Book (P/B) ratio of 2.65. Compared to its 3-year average P/B ratio of 1.77, the current P/B ratio is approximately 50.00% higher. Relative to its 5-year average P/B ratio of 2.13, the current P/B ratio is about 24.61% higher. Replimune Group Inc (REPL) has a Forward Free Cash Flow (FCF) yield of approximately -38.63%. Compared to its 3-year average FCF yield of -29.35%, the current FCF yield is approximately 31.61% lower. Relative to its 5-year average FCF yield of -20.31%, the current FCF yield is about 90.20% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for REPL competitors is 5840.66, providing a benchmark for relative valuation. Replimune Group Inc Corp (REPL.O) exhibits a P/S ratio of 19.77, which is -99.66% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of REPL increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of REPL in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is REPL currently overvalued or undervalued?

What is Replimune Group Inc (REPL) fair value?

REPL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Replimune Group Inc (REPL) is between 488.15 to 503.40 according to relative valuation method.

How does REPL's valuation metrics compare to the industry average?

The average P/S ratio for REPL's competitors is 5840.66, providing a benchmark for relative valuation. Replimune Group Inc Corp (REPL) exhibits a P/S ratio of 19.77, which is -99.66% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Replimune Group Inc (REPL) as of Mar 03 2026?

As of Mar 03 2026, Replimune Group Inc (REPL) has a P/B ratio of 2.65. This indicates that the market values REPL at 2.65 times its book value.

What is the current FCF Yield for Replimune Group Inc (REPL) as of Mar 03 2026?

As of Mar 03 2026, Replimune Group Inc (REPL) has a FCF Yield of -38.63%. This means that for every dollar of Replimune Group Inc's market capitalization, the company generates -38.63 cents in free cash flow.

What is the current Forward P/E ratio for Replimune Group Inc (REPL) as of Mar 03 2026?

As of Mar 03 2026, Replimune Group Inc (REPL) has a Forward P/E ratio of -3.13. This means the market is willing to pay $-3.13 for every dollar of Replimune Group Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Replimune Group Inc (REPL) as of Mar 03 2026?

As of Mar 03 2026, Replimune Group Inc (REPL) has a Forward P/S ratio of 19.77. This means the market is valuing REPL at $19.77 for every dollar of expected revenue over the next 12 months.

REPL Valuation